Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3355 |
|
| Actual shortage: | 217 (6%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3128 (93%) | |
Discontinuation Reports |
359 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 335 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
61 (25%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-WARFARIN | 5MG | TABLET | Resolved | 2020-07-08 | 2020-09-21 | 119773 |
| APO-WARFARIN | 5MG | TABLET | Resolved | 2020-07-29 | 2020-09-21 | 121343 |
| APO-WARFARIN | 5MG | TABLET | Resolved | 2020-10-21 | 2020-12-28 | 126780 |
| APO-ZOLMITRIPTAN | 2.5MG | TABLET | Resolved | 2017-10-12 | 2018-02-26 | 25646 |
| APO-ZOLMITRIPTAN RAPID | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-10-12 | 2018-09-12 | 25649 |
| APO-ZOLPIDEM ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2023-12-08 | 2024-02-23 | 212934 |
| APO-ZOLPIDEM ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-03-10 | 2017-04-10 | 245 |
| APO-ZOLPIDEM ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-03-10 | 2017-04-17 | 249 |
| APO-ZOLPIDEM ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2025-01-16 | 2025-02-07 | 247880 |
| APO-ZOLPIDEM ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2020-09-30 | 2020-11-19 | 125369 |
| APO-ZOLPIDEM ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2020-10-21 | 2020-11-19 | 126783 |
| APO-ZOLPIDEM ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2024-10-04 | 2024-12-06 | 239364 |
| APO-ZOLPIDEM ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2024-10-18 | 2024-10-25 | 240639 |
| APO-ZOLPIDEM ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2020-03-27 | 2020-05-11 | 109689 |
| APO-ZOLPIDEM ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2020-04-01 | 2020-05-11 | 110342 |
| APO-ZOLPIDEM ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2023-12-22 | 2024-02-23 | 214235 |
| APO-ZOPICLONE | 5MG | TABLET | Resolved | 2023-12-15 | 2024-02-23 | 213565 |
| APO-ZOPICLONE | 7.5MG | TABLET | Resolved | 2023-12-22 | 2024-02-23 | 214229 |
| APO-ZOPICLONE | 7.5MG | TABLET | Resolved | 2023-11-10 | 2023-11-24 | 209933 |
| APO-ZOPICLONE | 5MG | TABLET | Resolved | 2017-09-04 | 2018-01-19 | 20915 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60288 |
| APO-BOSENTAN | 62.5MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71339 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71342 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-09-07 | 2018-10-31 | 60291 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2020-11-16 | 2020-11-16 | 128438 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | To be discontinued | 2018-09-07 | 2018-09-07 | 60294 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
| APO-BROMAZEPAM | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
| APO-BROMAZEPAM | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
| APO-BROMAZEPAM | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
| APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
| APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
| APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |
| APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |